JP2024540107A5 - - Google Patents
Info
- Publication number
- JP2024540107A5 JP2024540107A5 JP2024525408A JP2024525408A JP2024540107A5 JP 2024540107 A5 JP2024540107 A5 JP 2024540107A5 JP 2024525408 A JP2024525408 A JP 2024525408A JP 2024525408 A JP2024525408 A JP 2024525408A JP 2024540107 A5 JP2024540107 A5 JP 2024540107A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- disease
- halogen
- structural part
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163276218P | 2021-11-05 | 2021-11-05 | |
| US63/276,218 | 2021-11-05 | ||
| PCT/US2022/079334 WO2023081845A1 (en) | 2021-11-05 | 2022-11-04 | Akt3 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540107A JP2024540107A (ja) | 2024-10-31 |
| JP2024540107A5 true JP2024540107A5 (enExample) | 2025-11-12 |
Family
ID=86242247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525408A Pending JP2024540107A (ja) | 2021-11-05 | 2022-11-04 | Ａｋｔ３モジュレーター |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4426289A4 (enExample) |
| JP (1) | JP2024540107A (enExample) |
| KR (1) | KR20240116620A (enExample) |
| CN (1) | CN118574610A (enExample) |
| AU (1) | AU2022380840A1 (enExample) |
| CA (1) | CA3236916A1 (enExample) |
| IL (1) | IL312441A (enExample) |
| MX (1) | MX2024005267A (enExample) |
| WO (1) | WO2023081845A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024251212A1 (en) * | 2023-06-06 | 2024-12-12 | Revir Therapeutics, Inc. | Isoindolinone and dihydropyrrolopridinone compounds and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100144733A1 (en) * | 2008-04-28 | 2010-06-10 | Institute For Oneworld Health | Compounds, compositions and methods comprising heteroaromatic derivatives |
| TWI558850B (zh) * | 2014-03-29 | 2016-11-21 | 精密聚合物股份有限公司 | 電子零件用處理液及電子零件之製造方法 |
| US11291719B2 (en) * | 2016-01-15 | 2022-04-05 | Augusta University Research Institute, Inc. | Methods and compositions for modulating Akt3 |
| US10342868B2 (en) * | 2016-01-15 | 2019-07-09 | Augusta University Research Institute, Inc. | Methods and compositions for inhibiting Akt3 |
| US10292978B2 (en) * | 2016-01-15 | 2019-05-21 | Augusta University Research Institute, Inc. | Specific Akt3 inhibitor and uses thereof |
| WO2021212111A1 (en) * | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
-
2022
- 2022-11-04 EP EP22891113.7A patent/EP4426289A4/en active Pending
- 2022-11-04 KR KR1020247018557A patent/KR20240116620A/ko active Pending
- 2022-11-04 JP JP2024525408A patent/JP2024540107A/ja active Pending
- 2022-11-04 MX MX2024005267A patent/MX2024005267A/es unknown
- 2022-11-04 CA CA3236916A patent/CA3236916A1/en active Pending
- 2022-11-04 AU AU2022380840A patent/AU2022380840A1/en active Pending
- 2022-11-04 IL IL312441A patent/IL312441A/en unknown
- 2022-11-04 WO PCT/US2022/079334 patent/WO2023081845A1/en not_active Ceased
- 2022-11-04 CN CN202280087304.9A patent/CN118574610A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| JP6554117B2 (ja) | 医療で使用されるインドール誘導体 | |
| CN111263767B (zh) | 作为干扰素基因调节剂的刺激剂的环状二核苷酸 | |
| JP2019501133A5 (enExample) | ||
| US8815918B2 (en) | Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives | |
| JP2013535460A5 (enExample) | ||
| JP2022505835A5 (enExample) | ||
| JP2016529324A5 (enExample) | ||
| CY1115836T1 (el) | Παραγωγα πυραζινονης και η χρηση τους στη θεραπευτικη αντιμετωπιση παθησεων των πνευμονων | |
| HRP20180916T1 (hr) | Inhibitori demetilaze od lsd1 na bazi arilciklopropilamina i njihova medicinska uporaba | |
| HRP20230452T1 (hr) | Modulatori piruvat kinaze i njihova uporaba | |
| BRPI0820112B8 (pt) | derivados de isoxazol-piridina, seu uso e processos de preparação e medicamento | |
| BR0316407A (pt) | Derivados de nucleosìdeo antiviral | |
| JP2018519343A5 (enExample) | ||
| CA2643177A1 (en) | Multi-cyclic compounds for treating cancer | |
| RU2011108024A (ru) | 3-азабицикло(3.1.0) гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов | |
| JP2014510774A5 (enExample) | ||
| JP2018537535A5 (enExample) | ||
| JP2021535112A5 (enExample) | ||
| RU2010140613A (ru) | Амиды диазабициклоалканов, селективные в отношении подтипа никотиновых ацетилхолиновых рецепторов | |
| JP2023164918A5 (enExample) | ||
| JP2024541995A5 (enExample) | ||
| JP2013507374A5 (enExample) | ||
| JP2014510147A5 (enExample) | ||
| TWI544920B (zh) | Ｎ－羥基－４－｛２－［３－（ｎ，ｎ－二甲基胺基甲基）苯並呋喃－２－基羰基胺基］乙氧基｝苯甲醯胺之新穎投藥法 |